Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply

Affiliations

¹ Diabetes Trials Unit, Churchill Hospital, University of Oxford, Oxford, Headington OX3 7LJ, UK. Electronic address: rury.holman@dtu.ox.ac.uk.
² Diabetes Trials Unit, Churchill Hospital, University of Oxford, Oxford, Headington OX3 7LJ, UK; Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria.
³ Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.

Comment

Rury R Holman et al. Lancet. 2014.

. 2014 Sep 20;384(9948):1097-8.

doi: 10.1016/S0140-6736(14)61674-3.

¹ Diabetes Trials Unit, Churchill Hospital, University of Oxford, Oxford, Headington OX3 7LJ, UK. Electronic address: rury.holman@dtu.ox.ac.uk.
² Diabetes Trials Unit, Churchill Hospital, University of Oxford, Oxford, Headington OX3 7LJ, UK; Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria.
³ Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.

No abstract available

Comment on

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
Holman RR, Sourij H, Califf RM. Holman RR, et al. Lancet. 2014 Jun 7;383(9933):2008-17. doi: 10.1016/S0140-6736(14)60794-7. Lancet. 2014. PMID: 24910232 Review.
Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes.
Yudkin JS, Vijan S, Sussman JB, Lehman R, Goldacre BM. Yudkin JS, et al. Lancet. 2014 Sep 20;384(9948):1095. doi: 10.1016/S0140-6736(14)61671-8. Lancet. 2014. PMID: 25241716 No abstract available.
Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes.
Boussageon R. Boussageon R. Lancet. 2014 Sep 20;384(9948):1096-7. doi: 10.1016/S0140-6736(14)61673-1. Lancet. 2014. PMID: 25241717 No abstract available.
Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes.
Vaccaro O, Masulli M, Bonora E, Del Prato S, Riccardi G; TOSCA.IT Study Group. Vaccaro O, et al. Lancet. 2014 Sep 20;384(9948):1096. doi: 10.1016/S0140-6736(14)61672-X. Lancet. 2014. PMID: 25241718 No abstract available.